Motoyuki Yoshida

1.5k citations

27 papers · 412 indexed · h-index 12

Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
Pharmacology
Hematology
Cancer Research
Cell Biology
- Aldose Reductase and Taurine 5
Pediatrics, Perinatology and Child Health
- Prenatal Substance Exposure Effects 4
Surgery
- Pancreatitis Pathology and Treatment 3
Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
Physiology
- Biochemical effects in animals 3
Molecular Biology
- Metabolomics and Mass Spectrometry Studies 2
- Fibroblast Growth Factor Research 2

Co-authors: Naoki Ashizawa Akira Mitoro Junichi Yamao Hitoshi Yoshiji Hiroshi Fukui Masayoshi Sawai Masahito Uemura Masao Fujimoto
Cited by: Hepatology Pharmacology Hematology
Journals: Journal of Hepatology (1 paper)International Journal of Pharmaceutics (1 paper)World Journal of Gastroenterology (1 paper)
Partner nations: Japan United States China

In The Last Decade

Motoyuki Yoshida

26 papers receiving 395 citations

Peers

Countries citing papers authored by Motoyuki Yoshida

Since Specialization

Citations

This map shows the geographic impact of Motoyuki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoyuki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoyuki Yoshida more than expected).

Fields of papers citing papers by Motoyuki Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoyuki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoyuki Yoshida. The network helps show where Motoyuki Yoshida may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Motoyuki Yoshida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Motoyuki Yoshida Line = papers co-authored together Motoyuki Yoshida links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease Hepatology Research ·Hiroaki Takaya,Shunichi Ueyama,Yui Osaki,Kosuke Kaji,Hideto Kawaratani,Ko Saito,Shigeyuki Aizawa,Tadashi Namisaki,Chie Morioka,Motoyuki Yoshida,Takemi Akahane,Hitoshi Yoshiji	2023	2
2	Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan Anticancer Research ·Naotaka Shimozato,Tadashi Namisaki,Akihiro Okano,Masaya Ohana,DAISUKE KINOSHITA,Toshihiko Kawasaki,Yosuke Aihara,Toshiya Nakatani,Hiroki Kinoshita,Tatsuichi Ann,KO SAITO,Motoyuki Yoshida,Hitoshi Yoshiji	2021	2
3	Treatment of long-segment Barrett’s adenocarcinoma by complete circular endoscopic submucosal dissection: a case report BMC Gastroenterology ·Miki Kaneko,Akira Mitoro,Motoyuki Yoshida,Masayoshi Sawai,Yasushi Okura,Masanori Furukawa,Tadashi Namisaki,Kei Moriya,Takemi Akahane,Hideto Kawaratani,Mitsuteru Kitade,Kousuke Kaji,Hiroaki Takaya,Yasuhiko Sawada,Kenichiro Seki,Shinya Sato,Tomomi Fujii,Junichi Yamao,Chiho Obayashi,Hitoshi Yoshiji	2018	4
4	Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance Oncology Reports ·Hitoshi Yoshiji,Ryuichi Noguchi,Tadashi Namisaki,Kei Moriya,Mitsuteru Kitade,Yosuke Aihara,Akitoshi Douhara,Junichi Yamao,Masao Fujimoto,Masahisa Toyohara,Akira Mitoro,Masayoshi Sawai,Motoyuki Yoshida,Chie Morioka,Masakazu Uejima,Masahito Uemura,Hiroshi Fukui	2013	16
5	Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report Journal of Medical Case Reports ·Yusaku Shirai,Hitoshi Yoshiji,Saiho Ko,Masaharu Yamazaki,Yasuhide Ikenaka,Ryuichi Noguchi,Chie Morioka,Kosuke Kaji,Yosuke Aihara,Keisuke Nakanishi,Junichi Yamao,Masahisa Toyohara,Akira Mitoro,Masayoshi Sawai,Motoyuki Yoshida,Masao Fujimoto,Masahito Uemura,Yoshiyuki Nakajima,Hiroshi Fukui	2011	2
6	Application to Classification of Mulberry Leaves using Multivariate Analysis of Proton NMR Metabolomic Data Natural Product Communications ·Eriko Fukuda,Motoyuki Yoshida,Masaki Baba,Yoshihiro Uesawa,Ryuichiro Suzuki,Osamu Kamo,Koji Tsubono,Kazunori Arifuku,Kazuhisa Yatsunami,Yoshihito Okada	2011	10
7	Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents Oncology Letters ·Hitoshi Yoshiji,Ryuichi Noguchi,Yasuhide Ikenaka,Kosuke Kaji,Yusaku Shirai,Yosuke Aihara,Junichi Yamao,Masahisa Toyohara,Akira Mitoro,Masayoshi Sawai,Motoyuki Yoshida,Chie Morioka,Masao Fujimoto,Masahito Uemura,Hideto Kawaratani,Tatsuhiro Tsujimoto,Hiroshi Fukui	2010	7
8	Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis World Journal of Gastroenterology ·Mitsuteru Kitade,Hitoshi Yoshiji,Ryuichi Noguchi,Yasuhide Ikenaka,Kosuke Kaji,Yusaku Shirai,Masaharu Yamazaki,Masahito Uemura,Junichi Yamao,Masao Fujimoto,Akira Mitoro,Masahisa Toyohara,Masayoshi Sawai,Motoyuki Yoshida,Chie Morioka,Tatsuhiro Tsujimoto,Hideto Kawaratani,Hiroshi Fukui	2009	37
9	Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma Journal of Hepatology ·Hitoshi Yoshiji,Ryuichi Noguchi,Masahisa Toyohara,Yasuhide Ikenaka,Mitsuteru Kitade,Kosuke Kaji,Masaharu Yamazaki,Junichi Yamao,Akira Mitoro,Masayoshi Sawai,Motoyuki Yoshida,Masao Fujimoto,Tatsuhiro Tsujimoto,Hideto Kawaratani,Masahito Uemura,Hiroshi Fukui	2009	76
10	Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis Scandinavian Journal of Gastroenterology ·Chie Morioka,Masahito Uemura,Tomomi Matsuyama,Masanori Matsumoto,Seiji Kato,Masatoshi Ishikawa,Hiromichi Ishizashi,Masao Fujimoto,Masayoshi Sawai,Motoyuki Yoshida,Akira Mitoro,Junichi Yamao,Tatsuhiro Tsujimoto,Hitoshi Yoshiji,Yasuyuki Urizono,Michiaki Hata,Kenji Nishino,Kazuo Okuchi,Yoshihiro Fujimura,Hiroshi Fukui	2008	25
11	Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE—famotidine or rebamipide in comparison by endoscopy) Journal of Gastroenterology ·Junichi Yamao,Eiryo Kikuchi,Masami Matsumoto,Masaki Nakayama,Tatsuichi Ann,Hideyuki Kojima,Akira Mitoro,Motoyuki Yoshida,Masaaki Yoshikawa,Hiroshi Yajima,Yoshizumi Miyauchi,Hiroshi Ono,Koichi Akiyama,Goro Sakurai,Yoshikazu Kinoshita,Ken Haruma,Yoshinori Takakura,Hiroshi Fukui	2007	21
12	Endoscopic extraction of biliary ascariasis by using a wire-guided basket, without a sphincterotomy Gastrointestinal Endoscopy ·Akira Mitoro,Masahide Yoshikawa,Junichi Yamao,Motoyuki Yoshida,K Kojima,Masayoshi Sawai,Hiroshi Fukui	2007	2
13	Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats International Journal of Pharmaceutics ·Kazuhiro Sasaki,Shingo Yonebayashi,Motoyuki Yoshida,Kenji Shimizu,Tomaji Aotsuka,Kozo Takayama	2003	39
14	An enzymatic assay for myo-inositol in tissue samples Journal of Biochemical and Biophysical Methods ·Naoki Ashizawa,Motoyuki Yoshida,Tomoji Aotsuka	2000	28
15	Antinociceptive Effect of the Combination of Pentazocine With Morphine in the Tail-Immersion and Scald-Pain Tests in Rats. The Japanese Journal of Pharmacology ·Hiroki Hamura,Motoyuki Yoshida,Kenji Shimizu,Takeo Matsukura,Hajime Suzuki,Minoru Narita,Tsutomu Suzuki	2000	13
16	Antinociceptive Effect of the Combination of Pentazocine With Morphine in the Tail-Immersion and Scald-Pain Tests in Rats The Japanese Journal of Pharmacology ·Hiroki Hamura,Motoyuki Yoshida,Kenji Shimizu,Takeo Matsukura,Hajime Suzuki,Minoru Narita,Tsutomu Suzuki	2000	4
17	Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: Minor contribution of nitric oxide Diabetes Research and Clinical Practice ·Motoyuki Yoshida,Yoshiko Sugiyama,Nobuhide Akaike,Naoki Ashizawa,Tomoji Aotsuka,Shigeo Ohbayashi,Akihiro Matsuura	1998	4
18	Effects of a Novel Potent Aldose Reductase Inhibitor, GP-1447, on Aldose Reductase Activity In Vitro and on Diabetic Neuropathy and Cataract Formation in Rats. The Japanese Journal of Pharmacology ·Naoki Ashizawa,Motoyuki Yoshida,Yoshiko Sugiyama,Nobuhide Akaike,Shigeo Ohbayashi,Tomoji Aotsuka,Naoki Abe,Kanako Fukushima,Akihiro Matsuura	1997	29
19	Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor Blood Coagulation & Fibrinolysis ·Hiroshi Mohri,Juichi Tanabe,Masahide Ohtsuka,Motoyuki Yoshida,S Motomura,Sachiyo Nishida,Yoshihiro Fujimura,Takao Okubo	1995	36
20	Role of hepatitis C virus(HCV) infection on liver injury in Sjoegren's syndrome(Sjs). Kanzo ·Hideyuki Kojima,Keiji Kitagami,Masahito UEMURA,Yoshinobu MATSUMURA,Motoyuki Yoshida,Hitoshi YOSHIJI,Yoshikazu SAKAGUCHI,Syuu IWASAWA,Kimio Nishimura,Tadashi HIGASHINO,Akira Takaya,Hiroshi Fukui,Tadasu TSUJII,Kazuhiro DOI	1994	1

About Motoyuki Yoshida

Motoyuki Yoshida is a scholar working on Hepatology, Genetics and Transplantation, having authored 27 papers that have together received 412 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (5 papers), Prenatal Substance Exposure Effects (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Pancreatitis Pathology and Treatment (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Biochemical effects in animals (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hepatology (85 citations), Pharmacology (36 citations) and Hematology (43 citations). Motoyuki Yoshida has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Naoki Ashizawa, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji, Hiroshi Fukui, Masayoshi Sawai, Masahito Uemura, Masao Fujimoto, Kenji Shimizu and Hideto Kawaratani. Their work appears in journals such as Journal of Hepatology, International Journal of Pharmaceutics and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact